Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era.

Autor: Vervecken E; Department of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium., Blaumeiser B; Center of Medical Genetics University Hospital and University of Antwerp Antwerp Belgium., Vanderheyden T; Department of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium., Hauspy J; Department of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium., Janssens K; Center of Medical Genetics University Hospital and University of Antwerp Antwerp Belgium.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2020 May 13; Vol. 8 (8), pp. 1461-1466. Date of Electronic Publication: 2020 May 13 (Print Publication: 2020).
DOI: 10.1002/ccr3.2889
Abstrakt: In the age of noninvasive prenatal testing, there is still an important role for invasive prenatal diagnosis, even for chromosomes 13, 18, and 21.
Competing Interests: None declared.
(© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje